BCD Bioscience is Biotechnology in United States that focus on immunomodulatory therapies business. Founded in 2019. They cover business area such as developer, naturally-derive oligosaccharide, food, agriculture, biopharmaceutical application, proprietary technology, novel oligosaccharide, natural product, a focus, ingredient, client, novel prebiotic, synbiotic, immunomodulatory therapy, human and animal health.
2019
( 5 years old in 2024 )
Immunomodulatory Therapies
-
231 G Street
Suite 24
Davis, CA 95616
United States
Private
developernaturally-derive oligosaccharidefoodagriculturebiopharmaceutical applicationproprietary technologynovel oligosaccharidenatural producta focusingredientclientnovel prebioticsynbioticimmunomodulatory therapyhuman and animal health
* We use standard office opening hours in near BCD Bioscience's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
BCD Bioscience is Biotechnology business from United States that founded in 2019 (5 years old in 2024), BCD Bioscience business is focusing on Immunomodulatory Therapies.
BCD Bioscience headquarter office and corporate office address is located in 231 G Street Suite 24 Davis, CA 95616 United States.
BCD Bioscience was founded in United States.
In 2024, BCD Bioscience is currently focus on immunomodulatory therapies sector.
Above is snippet of Google Trends for "immunomodulatory therapies" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with BCD Bioscience, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
